毕得医药：股东兰旦管理减持53.96万股公司股份

Core Viewpoint - Bid Pharma (688073.SH) announced a share reduction by Lan Dan Management through block trading, impacting the company's total shareholding structure [1] Group 1 - On November 13, 2025, Lan Dan Management reduced its holdings by a total of 539,600 shares, representing 0.59% of the company's total share capital [1] - Following this equity change, the combined shareholdings of Lan Dan Management, Xin Xi Management, and Wu Bo decreased from 10.11 million shares to 9.57 million shares [1] - The overall shareholding ratio of these entities fell from 11.12% to 10.53%, marking a change that touches the 1% threshold [1]